Biocon gets 6 observations from USFDA after inspection of its Bengaluru plant

Biocon is confident of addressing these expeditiously and remains committed to global standards of quality and compliance, the statement added.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XFMMLY
via IFTTT